Pharmacoeconomics and Health Policy: Current Applications and Prospects for the Future
Paul E. Greenberg
Howard G. Birnbaum
Mitchell B. Slavin
The use of pharmacoeconomic tools has grown dramatically in the past decade as provision of healthcare throughout the industrialised world has required increased cost consciousness. However, pharmacoeconomic analysis has not yet been fully exploited as a conceptual underpinning for public or private health policy decisions. Pharmacoeconomics is likely to become an increasingly important basis for health policy decisions as a number of significant dynamics evolve in the marketplace, including: 1. consumers acting on their growing access to information and becoming more actively involved in treatment decisions; 2. payers, providers and patients deepening their interaction and overcoming their traditional (narrow) focus on either costs or benefits alone; and 3. manufacturers being challenged by other healthcare constituencies as sponsors of cost-based outcomes studies.
In order to set up a list of libraries that you have access to,
you must first login
or sign up.
Then set up a personal list of libraries from your profile page by
clicking on your user name at the top right of any screen.